Skip to main content

Table 3 The sensitivity and specificity of the model in the estimation and validation group

From: A newly noninvasive model for prediction of non-alcoholic fatty liver disease: utility of serum prolactin levels

 

Cut-off

Estimation group

Validation group

non NAFLD

NAFLD

Sensitivity (%)

Specificity (%)

AUC (95%CI)

non NAFLD

NAFLD

Sensitivity (%)

Specificity (%)

AUC (95%CI)

Male

> − 0.79

46

118

95.9

55.3

0.87 (0.83–0.92)

46

119

95.2

54.5

0.86 (0.82–0.91)

<−0.79

57

5

55

6

> 1.71

5

63

51.2

95.1

9

64

51.2

91.1

< 1.71

98

60

92

61

Female

> − 0.68

26

104

94.5

74

0.91 (0.87–0.96)

41

102

97.1

61.3

0.82 (0.76–0.88)

<−0.68

74

6

65

3

> 2.16

3

57

51.8

97

5

52

34.0

91.4

< 2.16

97

53

53

101

  1. NAFLD Non-alcoholic fatty liver disease, AUC Area under the ROC curve